BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37405474)

  • 1. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
    Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
    Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
    PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer.
    Hsiao YY; Fu HC; Wu CH; Lan J; Ou YC; Tsai CC; Lin H
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of pretreatment tumor markers in a nomogram model for prognostic prediction of FIGO stage I endometrial cancer: A multi-institutional cohort study.
    Lin H; Wu CH; Ou YC; Huang SW; Fu HC
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1244-1256. PubMed ID: 38287783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer.
    Wang SC; Wu CH; Fu HC; Ou YC; Tsai CC; Chen YY; Wang YW; Hunag SW; Huang SY; Lan J; Lin H
    Int J Gynecol Pathol; 2023 Sep; ():. PubMed ID: 37732995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma.
    Guo X; Lin C; Zhao J; Tang M
    BMC Cancer; 2022 Dec; 22(1):1333. PubMed ID: 36539714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
    Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
    Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
    Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer.
    Ünsal M; Kimyon Comert G; Karalok A; Basaran D; Turkmen O; Boyraz G; Tasci T; Koc S; Boran N; Tulunay G; Turan T
    Ginekol Pol; 2018; 89(11):599-606. PubMed ID: 30508211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of preoperative serum carcinoembryonic antigen levels in the prediction of lymph node metastasis and prognosis in locally advanced gastric cancer: a retrospective analysis.
    Wang K; Jiang X; Ren Y; Ma Z; Cheng X; Li F; Xiao J; Yu Z; Jiao Z
    BMC Gastroenterol; 2020 Apr; 20(1):100. PubMed ID: 32276616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients.
    Zhao LY; Yin Y; Li X; Zhu CJ; Wang YG; Chen XL; Zhang WH; Chen XZ; Yang K; Liu K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Oncotarget; 2016 Sep; 7(37):59630-59639. PubMed ID: 27449100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram prediction model for lymph node metastasis in endometrial cancer patients.
    Wang Z; Zhang S; Ma Y; Li W; Tian J; Liu T
    BMC Cancer; 2021 Jun; 21(1):748. PubMed ID: 34187416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for pelvic lymph node metastasis in endometrial cancer.
    Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
    Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
    Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
    Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer.
    Lee J; Kong TW; Paek J; Chang SJ; Ryu HS
    Int J Gynecol Cancer; 2016 Nov; 26(9):1630-1635. PubMed ID: 27654258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
    Stålberg K; Kjølhede P; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Falconer H; Holmberg E; Staf C; Tholander B; Åvall-Lundqvist E; Rosenberg P; Högberg T
    Int J Cancer; 2017 Jun; 140(12):2693-2700. PubMed ID: 28340503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome score as an indicator in a predictive nomogram for lymph node metastasis in endometrial cancer.
    Feng X; Li XC; Yang X; Cheng Y; Dong YY; Wang JY; Zhou JY; Wang JL
    BMC Cancer; 2023 Jul; 23(1):622. PubMed ID: 37403054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy.
    Imai K; Kato H; Katayama K; Nakanishi K; Kawano A; Iura A; Konnai K; Onose R; Hirahara F; Miyagi E
    Gynecol Oncol; 2016 Aug; 142(2):273-7. PubMed ID: 27268220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.